Cellectis Valuation
| CLLS Stock | USD 3.99 0.07 1.72% |
At this time, the firm appears to be overvalued. Cellectis SA shows a prevailing Real Value of $3.46 per share. The current price of the firm is $3.99. Our model approximates the value of Cellectis SA from analyzing the firm fundamentals such as Current Valuation of 294.86 M, return on equity of -0.31, and Profit Margin of (0.43) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cellectis' valuation include:
Price Book 3.914 | Enterprise Value | Enterprise Value Ebitda (3.90) | Price Sales 4.9368 | Enterprise Value Revenue 3.9173 |
Overvalued
Today
Please note that Cellectis' price fluctuation is very risky at this time. Calculation of the real value of Cellectis SA is based on 3 months time horizon. Increasing Cellectis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cellectis stock is determined by what a typical buyer is willing to pay for full or partial control of Cellectis SA. Since Cellectis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cellectis Stock. However, Cellectis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.99 | Real 3.46 | Target 7.0 | Hype 3.99 | Naive 3.75 |
The intrinsic value of Cellectis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cellectis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cellectis SA helps investors to forecast how Cellectis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cellectis more accurately as focusing exclusively on Cellectis' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cellectis' intrinsic value based on its ongoing forecasts of Cellectis' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cellectis' closest peers.
Cellectis Cash |
|
Cellectis Total Value Analysis
Cellectis SA is currently expected to have valuation of 294.86 M with market capitalization of 407.54 M, debt of 91.46 M, and cash on hands of 153.13 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cellectis fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
294.86 M | 407.54 M | 91.46 M | 153.13 M |
Cellectis Investor Information
About 14.0% of the company shares are held by institutions such as insurance companies. The book value of Cellectis was currently reported as 1.39. The company recorded a loss per share of 0.33. Cellectis SA had not issued any dividends in recent years. Based on the key indicators related to Cellectis' liquidity, profitability, solvency, and operating efficiency, Cellectis SA is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.Cellectis Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cellectis has an asset utilization ratio of 10.82 percent. This implies that the Company is making $0.11 for each dollar of assets. An increasing asset utilization means that Cellectis SA is more efficient with each dollar of assets it utilizes for everyday operations.Cellectis Profitability Analysis
Based on Cellectis' profitability indicators, Cellectis SA may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Cellectis' ability to earn profits and add value for shareholders.Net Loss | First Reported 2012-09-30 | Previous Quarter -23.7 M | Current Value 589 K | Quarterly Volatility 14.5 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.026 | 0.0274 |
|
|
For Cellectis profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cellectis SA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cellectis utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cellectis's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cellectis over time as well as its relative position and ranking within its peers.
Cellectis Earnings per Share Projection vs Actual
By analyzing Cellectis' earnings estimates, investors can diagnose different trends across Cellectis' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Cellectis SA is based on EPS before non-recurring items and includes expenses related to employee stock options.Cellectis Ownership Allocation
Cellectis holds a total of 72.33 Million outstanding shares. Almost 85.57 percent of Cellectis outstanding shares are held by general public with 14.43 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cellectis Profitability Analysis
The company reported the previous year's revenue of 41.51 M. Net Loss for the year was (36.7 M) with profit before overhead, payroll, taxes, and interest of 82.55 M.About Cellectis Valuation
The stock valuation mechanism determines Cellectis' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Cellectis SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cellectis. We calculate exposure to Cellectis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cellectis's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 37.2 M | 23.6 M | |
| Pretax Profit Margin | (1.02) | (1.07) | |
| Operating Profit Margin | (1.65) | (1.73) | |
| Net Loss | (1.02) | (1.07) | |
| Gross Profit Margin | 0.03 | 0.03 |
Cellectis Current Valuation Indicators
Cellectis' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cellectis' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cellectis, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cellectis' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cellectis' worth.Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.